A

Alkermes plc
D

ALKS

29.060
USD
0.80
(2.83%)
مغلق
حجم التداول
77,520
الربح لكل سهم
1
العائد الربحي
-
P/E
14
حجم السوق
4,797,166,070
أصول ذات صلة
ABBV
ABBV
2.030
(0.99%)
206.710 USD
AZN
AZN
0.700
(0.89%)
79.180 USD
BMY
BMY
0.645
(1.35%)
48.465 USD
GILD
GILD
-0.680
(-0.57%)
118.320 USD
JNJ
JNJ
1.930
(1.10%)
176.650 USD
LLY
LLY
16.80
(2.45%)
701.25 USD
MRK
MRK
1.500
(1.81%)
84.250 USD
NVS
NVS
2.080
(1.70%)
124.210 USD
PFE
PFE
0.055
(0.22%)
25.155 USD
SNY
SNY
0.745
(1.52%)
49.770 USD
TEVA
TEVA
0.310
(1.77%)
17.855 USD
المزيد
الأخبار المقالات

العنوان: Alkermes plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.